Magazine Article | March 7, 2018

Study Proves Importance Of Patient Diversity In Clinical Trials

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader

Drs. Roxana Mehran, Wayne Batchelor, and Paul Underwood were frustrated. They knew there was a big problem with clinical trials in the cardiovascular space — namely, that a very small percentage of trial participants were women or minorities. That left all conclusions regarding outcomes of even successful trials mostly tied to white males. Their frustration, and the need for diversity in these trials, was underscored by two key facts:

  • Coronary disease is the leading killer in America.
  • The U.S. Census Bureau estimates that by the year 2050, more than half of the U.S. population will be non-white.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader